Denali Therapeutics Inc (DNLI)
14.96
-0.60
(-3.86%)
USD |
NASDAQ |
Apr 25, 16:00
14.98
+0.02
(+0.13%)
After-Hours: 20:00
Denali Therapeutics Free Cash Flow (Quarterly): -100.89M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -100.89M |
| September 30, 2023 | -89.43M |
| June 30, 2023 | -119.02M |
| March 31, 2023 | -61.59M |
| December 31, 2022 | -77.51M |
| September 30, 2022 | -63.10M |
| June 30, 2022 | -45.79M |
| March 31, 2022 | -76.15M |
| December 31, 2021 | -68.55M |
| September 30, 2021 | -43.31M |
| June 30, 2021 | -54.99M |
| March 31, 2021 | -53.04M |
| December 31, 2020 | 512.72M |
| September 30, 2020 | -0.62M |
| Date | Value |
|---|---|
| June 30, 2020 | -43.67M |
| March 31, 2020 | -55.37M |
| December 31, 2019 | -50.42M |
| September 30, 2019 | -33.28M |
| June 30, 2019 | -53.45M |
| March 31, 2019 | -32.35M |
| December 31, 2018 | 91.75M |
| September 30, 2018 | -35.67M |
| June 30, 2018 | -42.40M |
| March 31, 2018 | 33.04M |
| December 31, 2017 | -19.41M |
| September 30, 2017 | -22.29M |
| June 30, 2017 | -18.14M |
| March 31, 2017 | -19.68M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-119.02M
Minimum
Jun 2023
512.72M
Maximum
Dec 2020
-30.39M
Average
-54.99M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
| Halozyme Therapeutics Inc | 99.76M |
| AIM ImmunoTech Inc | -9.956M |
| Perspective Therapeutics Inc | -9.097M |
| Protalix BioTherapeutics Inc | 3.345M |
| Armata Pharmaceuticals Inc | -10.51M |